... sequential IE 2-cycle adjuvant chemotherapy regimen. Conclusion: This case highlights the diagnostic difficulty and rapid progression of renal Ewing sarcoma. Accurate diagnosis relies on integrated imaging, histopathology, immunoprofiling, and molecular testing. Early recognition and multidisciplinary...

... failure of first-line therapies. There is a need for novel treatment options for patients with recurrent or metastatic TGCTs, notably for those that are not sensitive to first-line chemotherapy. With the development of next-generation sequencing technologies, an increasing number of gene mutations has...

...Jinhyung Jeon; Jae Heon Kim; Jee Soo Ha; Won Jae Yang; Kang Su Cho; Do Kyung Kim Introduction: The objective of this study was to determine effects of adjuvant chemotherapy (AC) on survival outcomes compared to surgery alone without AC for upper tract urothelial carcinoma (UTUC) patients...

... ]. This highlights the aggressive nature of SCC of the bladder and the need for early detection and aggressive management. Recent studies suggest that neoadjuvant chemotherapy could improve the outcome of SCC bladder cancer in patients. The efficacy of immunotherapy for treating SCC bladder cancer is also under...

... treatment response and survival. Methods: One hundred and fifty-six patients with penile carcinoma treated with chemotherapy were included in this retrospective study. The mGPS before chemotherapy was classified into 3 groups (mGPS 0 [CRP <10, any albumin], mGPS 1 [CRP >10 mg/L, albumin >35 g/L...

...Yiduo Wang; Huan Qu; Bin Xu; Jianping Wu; Kai Lu; Chunhui Liu; Shuqiu Chen; Ming Chen Purpose: Cisplatin-containing combination chemotherapy has been the standard of care since the late 1980s, but the response rate is <50%. Studies have shown that the efficiency of chemotherapy differs among...

... chemotherapy protocols and high-dose chemotherapy, and he was started on sunitinib (50 mg/day, 4/2-scheme). After 3 months of treatment, AFP serum concentrations had normalized and no significant treatment-associated side effects were observed. Therapy is still ongoing, and the patient is without evidence...

..., clinical stage (CS), chemotherapy, use of a central venous access device (CVA). Data analysis involved descriptive statistical methods with multivariable analysis to identify independent risk factors. Results: Twenty-three TEEs (7.3%) were observed, 18 deep vein thromboses, 4 pulmonary embolisms, and 1...

.... And there were 2 patients diagnosed at 34 and 50 years old respectively. Symptoms of these patients were similar to patients with prostate adenocarcinoma. Serum prostate specific antigen of 7 patients was at normal level. Five patients received chemotherapy, average overall survival (OS) was 9.75 months; 3 only...

...Judith Stangl-Kremser; Andrea Mari; David D’Andrea; Shoji Kimura; Irene Resch; Shahrokh F. Shariat; Tobias Klatte Purpose: We hypothesized sarcopenia as predictive factor as a response to upfront chemotherapy of muscle-invasive urothelial bladder cancer (MIBC). Methods: We retrospectively studied...

...Isabel Heidegger; Daniel Porres; Nica Veek; Axel Heidenreich; David Pfister Background: Malignancies and cisplatin-based chemotherapy are both known to correlate with a high risk of venous thrombotic events (VTT). In testicular cancer, the information regarding the incidence and reason of VTT...

... and internal iliac lymph node metastases. Transrectal biopsy confirmed embryonal rhabdomyosarcoma of the prostate classified as cT2bN1M1 (stage IV) by the International Rhabdomyosarcoma Study (IRS) Group staging system. Systemic chemotherapy was started according to the IRS III regimen 36, which consisted...

... to the presence of a scrotum black papule for 20 months. Wide local excision was performed, and histology revealed a malignant melanoma. Chest and abdominal CT revealed metastatic disease, so chemotherapy, immunotherapy and radiotherapy were administered. We describe the evolution over 1 year in this unusual...

... as an HSP27-mediated proliferation benefit in the presence of AA as shown in docetaxel incubation studies. Conclusion: In contrast to repeatedly demonstrated HSP27-driven chemoresistance related to chemotherapeutics, our results may constitute a broader molecular mode of action of AA chemotherapy. AA efficacy...

... prognosis with a median survival rate of approximately 6 months, which can be prolonged for up to 14 months with palliative systemic chemotherapy. We present the case of a 61-year-old male patient diagnosed with localized MIBC 10 years ago. He underwent nerve-sparing radical cystectomy with ileal neobladder...

...Thomas Worst; Lisa Sautter; Axel John; Christel Weiss; Axel Häcker; Julia Heinzelbecker Objective: Despite the low local toxicity of the used agents, Cisplatin-based chemotherapy (CBP) for patients with testicular germ cell tumors (TGCT) is mostly delivered via a central venous access (CVA). Since...

... resection (TUR) and/or cystectomy, chemotherapy, and/or radiation for small cell carcinoma of the bladder at our institution. Results: The median follow-up for survivors was 34 months. Patients presented most often with muscle-invasive disease (T2-4 - 89%), and 21% had lymph node/distant metastases. Tobacco...

... complete response to FOLFOX4 (fluorouracil, leucovorin, oxaliplatin) chemotherapy regimen. Case Report: A 41-year-old man was admitted to our hospital with a diagnosis of primary adenocarcinoma of the bladder. Due to the similarity in histology with colon carcinoma, a FOLFOX4 regimen was started. Complete...

...S. Ramsey; G. Kerr; G.C.W. Howard; R. Donat Objective: To examine the outcome of orchidectomy following primary chemotherapy in patients with metastatic testicular cancer. Patients and Methods: This was a retrospective analysis of patients who underwent primary chemotherapy without initial...

... evaluated patterns of failure and prognostic factors in 57 patients with pT2 or more tumors. Adjuvant chemotherapy was applied in 25 patients. Results: Recurrences occurred in a total of 23 patients, and 20 of these experienced some kind of locoregional failure during follow-up. The overall crude...